| dbo:abstract
|
- Xiangxue Pharmaceutical Co., Ltd. also known as XPH, is a Chinese pharmaceutical company. It was headquartered in Guangzhou Economic and Technological Development Zone, Guangzhou, the capital of the Guangdong Province. The company started in a place that near to the tourist spot (now in the Luogang Subdistrict, Huangpu District), thus called itself Xiangxue (Chinese: 香雪; pinyin: Xiāng xuě; Jyutping: hoeng1 syut3; lit. 'Fragrant Snow'). Xiangxue Pharmaceutical was a constituent of SZSE 200 Index (mid-cap index), but was removed in January 2017; it was inserted to (small-cap index) instead at the same time. SZSE 200, 300 and 700 Indexes are subsets of , the latter is a stock market index for the top 1,000 companies by free-float adjusted capitalization. In July 2017 Xiangxue was also removed from SZSE Component Index, an index for top 500 companies of the exchange. (en)
- 广州市香雪制药股份有限公司（英语：Guangzhou Xiangxue Pharmaceutical Co., Ltd， 深交所：300147，证券简称：香雪制药），是一家中国大陆从事医药产业的公司，成立于1986年，公司原名广州萝岗制药厂，1997年更名为广州市香雪制药股份有限公司。该公司的名称“香雪”取自羊城八景之一萝岗香雪。2010年12月15日在深圳证券交易所创业板挂牌上市。 香雪制药在广东、北京、山西、四川、重庆、安徽、云南和宁夏等地设立十八间公司，拥有GMP生产基地和GAP药材种植基地，产品涵盖中药饮片、中成药、功能健康食品（饮料）、养生保健等领域。 “香雪”商标为中国驰名商标，2009年公司营业收入为3.79亿元人民币，净利润为5,205.53万元人民币。 该公司为2010年亚洲运动会独家药品供应商，2002-2003年间，该公司曾拥有广州香雪足球队（现为广州足球俱乐部）。 (zh)
|
| dbo:assets
| |
| dbo:equity
| |
| dbo:foundingYear
| |
| dbo:netIncome
| |
| dbo:operatingIncome
| |
| dbo:revenue
| |
| dbo:revenueYear
| |
| dbo:thumbnail
| |
| dbo:type
| |
| dbo:wikiPageID
| |
| dbo:wikiPageLength
|
- 11129 (xsd:nonNegativeInteger)
|
| dbo:wikiPageRevisionID
| |
| dbo:wikiPageWikiLink
| |
| dbp:altname
|
- Xiangxue Pharmaceutical (en)
|
| dbp:assets
| |
| dbp:assetsYear
| |
| dbp:c
| |
| dbp:equity
| |
| dbp:equityYear
| |
| dbp:footnotes
|
- in consolidated financial statement (en)
|
| dbp:hqLocationCity
| |
| dbp:hqLocationCountry
| |
| dbp:incomeYear
| |
| dbp:j
|
- can4 suk6 mui4 (en)
- hoeng1 syut3 (en)
- hoeng1 syut3 zai3 joek6 (en)
- wong4 wing5 fai1 (en)
|
| dbp:l
|
- Fragrant Snow (en)
- Huazhou Chinese Medicine Factory (en)
- Guangzhou City Xiangxue Pharmaceutical, Company Limited by Shares (en)
|
| dbp:logo
| |
| dbp:name
|
- Xiangxue Pharmaceutical (en)
|
| dbp:netIncome
| |
| dbp:netIncomeYear
| |
| dbp:operatingIncome
| |
| dbp:order
| |
| dbp:owner
| |
| dbp:p
|
- Chén Shū Méi (en)
- Shàng qīng yǐn liáng chá (en)
- Wáng Yǒng Huī (en)
- Xiāng xuě (en)
- Xiāng xuě zhì yào (en)
|
| dbp:revenue
|
- (en)
- CNY 1.862 1,000,000,000 (en)
|
| dbp:revenueYear
| |
| dbp:s
|
- 香雪制药 (en)
- 上清饮凉茶 (en)
- 化州中药厂 (en)
- 广州市香雪制药股份有限公司 (en)
- 王永辉 (en)
- 陈淑梅 (en)
|
| dbp:t
|
- 香雪製葯ref| could be written as in traditional Chinese character|group="nb" (en)
|
| dbp:title
|
- Xiangxue Pharmaceutical Co., Ltd. (en)
|
| dbp:type
| |
| dbp:wikiPageUsesTemplate
| |
| dcterms:subject
| |
| rdf:type
| |
| rdfs:comment
|
- 广州市香雪制药股份有限公司（英语：Guangzhou Xiangxue Pharmaceutical Co., Ltd， 深交所：300147，证券简称：香雪制药），是一家中国大陆从事医药产业的公司，成立于1986年，公司原名广州萝岗制药厂，1997年更名为广州市香雪制药股份有限公司。该公司的名称“香雪”取自羊城八景之一萝岗香雪。2010年12月15日在深圳证券交易所创业板挂牌上市。 香雪制药在广东、北京、山西、四川、重庆、安徽、云南和宁夏等地设立十八间公司，拥有GMP生产基地和GAP药材种植基地，产品涵盖中药饮片、中成药、功能健康食品（饮料）、养生保健等领域。 “香雪”商标为中国驰名商标，2009年公司营业收入为3.79亿元人民币，净利润为5,205.53万元人民币。 该公司为2010年亚洲运动会独家药品供应商，2002-2003年间，该公司曾拥有广州香雪足球队（现为广州足球俱乐部）。 (zh)
- Xiangxue Pharmaceutical Co., Ltd. also known as XPH, is a Chinese pharmaceutical company. It was headquartered in Guangzhou Economic and Technological Development Zone, Guangzhou, the capital of the Guangdong Province. The company started in a place that near to the tourist spot (now in the Luogang Subdistrict, Huangpu District), thus called itself Xiangxue (Chinese: 香雪; pinyin: Xiāng xuě; Jyutping: hoeng1 syut3; lit. 'Fragrant Snow'). (en)
|
| rdfs:label
|
- Xiangxue Pharmaceutical (en)
- 香雪制药 (zh)
|
| rdfs:seeAlso
| |
| owl:sameAs
| |
| prov:wasDerivedFrom
| |
| foaf:depiction
| |
| foaf:isPrimaryTopicOf
| |
| foaf:name
|
- Xiangxue Pharmaceutical (en)
|
| is dbo:owner
of | |
| is dbo:wikiPageDisambiguates
of | |
| is dbo:wikiPageRedirects
of | |
| is dbo:wikiPageWikiLink
of | |
| is dbp:owner
of | |
| is foaf:primaryTopic
of | |
